首页> 外文期刊>Investigative ophthalmology & visual science >Statins modulate heat shock protein expression and enhance retinal ganglion cell survival after transient retinal ischemia/reperfusion in vivo.
【24h】

Statins modulate heat shock protein expression and enhance retinal ganglion cell survival after transient retinal ischemia/reperfusion in vivo.

机译:他汀类药物调节体内短暂性视网膜缺血/再灌注后的热休克蛋白表达并增强视网膜神经节细胞的存活。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To evaluate putative mechanisms for the pleiotropic effects of statins, the expression of members of the heat shock family of proteins (HSPs) was compared between normal and ischemic rat retinas after transient retinal ischemia/reperfusion and statin treatment in vivo. METHODS: Retinal ischemia/reperfusion was induced by transient elevation of intraocular pressure (IOP). Retinal expression of HSPs was evaluated at different time points after drug and solvent injection and retinal ischemia/reperfusion by means of PCR and Western blot analysis. Immunofluorescent staining and confocal laser scanning microscopy were used to localize the expression of HSPs in normal and ischemic retinas. RESULTS: During the acute phase after retinal ischemia, alphaB-crystallin protein and mRNA expression were reduced after statin treatment. After 72 hours of reperfusion, statins increased the expression of alphaB-crystallin and reduced the expression of HSP27 in the retina. Increased expression of alphaB-crystallinearly after lesion and statin delivery correlated with increased expression of the heat shock factors 1 and 2. Statins significantly enhanced retinal ganglion cell (RGC) survival 10 days after transient retinal ischemia in vivo. CONCLUSIONS: Systemic delivery of statins after a transient period of retinal ischemia significantly modulated HSP expression in the retina and enhanced RGC survival. Together, these results support the notion that statins constitute a feasible therapeutic approach to prevent some of the neuronal damage in the acute and possibly also the delayed phase and have beneficial effects in central nervous system (CNS) disorders directly affecting the visual system.
机译:目的:为了评估他汀类药物的多效作用的推定机制,比较了短暂和局部视网膜缺血/再灌注以及他汀类药物在体内治疗后正常和缺血大鼠视网膜中热休克蛋白(HSP)成员的表达。方法:眼内压(IOP)的短暂升高引起视网膜缺血/再灌注。通过PCR和Western印迹分析,在药物和溶剂注射以及视网膜缺血/再灌注后的不同时间点评估HSP的视网膜表达。免疫荧光染色和共聚焦激光扫描显微镜用于定位正常和缺血性视网膜中HSP的表达。结果:在视网膜缺血后的急性期,他汀类药物治疗后αB-晶状体蛋白和mRNA表达降低。再灌注72小时后,他汀类药物增加了视网膜中αB-晶状体蛋白的表达并降低了HSP27的表达。病变和他汀类药物递送后,αB晶体表达的增加与热休克因子1和2的表达增加相关。他汀类药物显着增强了体内短暂性视网膜缺血后10天的视网膜神经节细胞(RGC)存活率。结论:短暂的视网膜缺血期后,他汀类药物的全身递送显着调节了视网膜中HSP的表达并提高了RGC的存活率。总之,这些结果支持了他汀类药物构成了一种可行的治疗方法,可以预防急性阶段的某些神经元损害,也可以预防延迟期,并且对直接影响视觉系统的中枢神经系统(CNS)疾病具有有益作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号